## **TRUSTEES’ REPORT FOR THE YEAR ENDED 31 MAY 2025**
## **REFERENCE AND ADMINISTRATIVE DETAILS**
## **Charity name:** Military vs Cancer **Charity registration number:** 1199115 **CIO registration number:** CE029275
**Registered office:** Armstrong House, First Avenue, Finningley, Doncaster, DN9 3GA
**Legal structure:** Charitable Incorporated Organisation (CIO) – Foundation model.
## **Trustees serving during the 2024/2025 financial year**
The following trustees served during the year:
- N Banner
- M Barnes
- G Evans
- M Howarth
- P Moody
- C Nicholson (Chair)
## **Trustees serving during the 2025/26 financial year**
- N Banner (resigned 03/08/25)
- M Barnes
- C Box
- D Roscoe aka S Dennis (resigned 18/02/26)
- G Evans
- M Howarth (resigned 02/08/25)
- P Moody
- S Morris
- C Nicholson (Chair)
All trustees are unpaid volunteers and bring a blend of military, commercial and professional experience to the charity’s governance.
## **Professional advisers**
## **Independent examiner and accountants**
Accounting for Good CIC
2 Geordie Ridley Place Upper Precinct Wesley Court Blaydon on Tyne Tyne and Wear NE21 5BT
## **Bankers**
Lloyds Bank
**Military vs Cancer** Armstrong House, First Avenue, Finningley, Doncaster, DN9 3GA
**Tel +44 (0) 7469 550 679 info@militaryvscancer.com www.militaryvscancer.com**
_A CIO registered with the Charities Commission in England & Wales Charity No 1199115_
**i**
**TRUSTEES’ REPORT FY 2024-25 : 2**
**MILITARY VS CANCER**
## **STRUCTURE, GOVERNANCE AND MANAGEMENT**
Military vs Cancer is governed by a Board of Trustees in accordance with its CIO constitution. The Board is responsible for setting strategy, overseeing risk and safeguarding the charity’s assets. Operational delivery and day-to-day management are delegated to a small staff team and volunteers, within budgets and parameters agreed by the trustees.
The trustees meet regularly during the year, receive financial and operational reports, and review performance against plan. New trustees are appointed in line with the constitution, complete a declaration of interests and receive an induction pack covering our governing document, Charity Commission guidance on trustee responsibilities and our grant-making approach.
Conflicts of interest are managed through annual declarations and a standing agenda item at each Board meeting. No trustee received any remuneration or other private benefit during the year, other than reimbursement of properly incurred expenses.
## **Risk management**
The trustees keep the principal risks under regular review. The main risks identified for the year included:
- **Income concentration risk** from reliance on large-scale events and community fundraising.
- **Operational capacity risk** as demand for support grows faster than volunteer capacity.
- **Reputational risk** as a small, relatively young charity operating in the Armed Forces and cancer space.
- **Financial risk** from running a planned deficit and drawing down reserves.
Mitigations include diversification of income, close monitoring of event performance, investment in modest staff capacity, documented financial controls, and regular review of reserves against the agreed policy.
## **OBJECTIVES AND ACTIVITIES**
## **Charitable objects during the year**
For the year ended 31 May 2025, the charity’s objects, as set out in its CIO constitution and on the charity register, were broadly to relieve need, hardship and distress arising from cancer, primarily by making grants and supporting projects that provide diagnosis, treatment, care, research, education and emotional support to patients and their families.
In practical terms, the trustees focused on supporting serving and former members of the UK Armed Forces, and their families, who are affected by cancer. We do this mainly by providing financial assistance and practical support at times of acute need, and by working with partners to offer information, signposting and other help along the cancer journey.
**Registered in England & Wales | Charity No. 1199115**
**TRUSTEES’ REPORT FY 2024-25 : 3**
**MILITARY VS CANCER**
## **Public benefit**
The trustees have had regard to the Charity Commission’s guidance on public benefit when setting the charity’s objectives and planning activities.
The charity delivers public benefit by:
- Relieving financial hardship for members of the Armed Forces community affected by cancer and their families.
- Providing timely, targeted grants which enable people to remain at home, attend treatment, or spend meaningful time together.
- Supporting carers and family members whose own wellbeing and resilience are under significant strain.
Support is provided on the basis of need and vulnerability, not rank, branch of service or background.
## **Activities in the year**
Military vs Cancer is a grant-giving and support charity. During the year we:
- Awarded individual grants to beneficiaries and families affected by cancer, helping with costs such as home adaptations, travel to treatment, accommodation, respite and memory-making activities.
- Worked with partner organisations, medical professionals and welfare teams to identify those most in need and to respond quickly and sensitively.
- Raised funds through events, crowdfunding, individual giving and corporate donations to sustain and grow our grant-making.
Applications are assessed by or on behalf of the trustees, against criteria that reflect our objects, our safeguarding responsibilities and the funds currently available.
Grants are made at the trustees’ discretion and are monitored to ensure they are used for their intended purpose.
## **ACHIEVEMENTS AND PERFORMANCE**
## **Fundraising and income**
Total income for the year was **£277,654** (2024: £195,700). This comprised:
- **Events and crowdfunding:** £178,242 (2024: £170,948)
- **Donations and legacies (including corporate donations):** £87,193 (2024: £21,379)
- **Grant income (charitable activities – restricted):** £10,000 (2024: £nil)
- **Other income:** £2,219 (2024: £3,373)
The trustees are encouraged by continued strength in event income and by significant growth in donations, including support from corporate partners and major donors.
The £10,000 restricted grant provided by the Armed Forces towards Armed Forces Day costs reflects increasing external confidence in our work.
**Registered in England & Wales | Charity No. 1199115**
**TRUSTEES’ REPORT FY 2024-25 : 4**
**MILITARY VS CANCER**
## **Grant-making and support**
Total expenditure on charitable activities was **£46,170** (2024: £79,849), including:
- **Grants made to individuals:** £27,361 (2024: £44,224)
- **Subcontract costs:** £5,160 (2024: £35,625)
- **Charitable staff costs:** £61,595 (2024: £nil)
Grant volumes and values vary year on year depending on the timing and complexity of cases.
The reduction compared to 2024 reflects the pattern of applications received rather than a change in priorities. The trustees’ intention is to grow grant-making over the medium term as capacity and sustainable income increase.
The support provided during the year enabled beneficiaries to:
- Remain at home with appropriate adaptations and equipment.
- Attend specialist treatment centres, with travel and accommodation costs covered.
- Enjoy much-needed respite and memory-making experiences with their families.
## **Investment in capacity**
During the year the trustees made a conscious decision to invest in organisational capacity by employing staff for the first time.
Total staff costs across fundraising, charitable activities and support functions were **£61,595** (2024: £nil), with additional staff-related costs included within fundraising and charitable expenditure.
This investment was designed to:
- Professionalise and grow fundraising, particularly with corporates and major donors.
- Strengthen case management and beneficiary support.
- Improve governance, financial management and compliance as income passes £250,000.
The trustees expect this investment to support improved fundraising performance, increased grant-making and a stronger supporter experience in future years.
## **FINANCIAL REVIEW**
## **Results for the year**
Total expenditure for the year was **£324,749** (2024: £179,722), resulting in a **net deficit of £47,095** (2024: surplus £15,978). Total funds at year end were **£47,839** (2024: £94,934), all of which were unrestricted.
The deficit was planned and reflects:
- A deliberate increase in fundraising and event expenditure to build income and profile.
**Registered in England & Wales | Charity No. 1199115**
**TRUSTEES’ REPORT FY 2024-25 : 5**
**MILITARY VS CANCER**
- The introduction of staff costs to support fundraising, grant-making and administration.
- A normal year-to-year variation in grant volumes.
The trustees consider this to be an investment phase and are monitoring performance closely to ensure that the deficit is not repeated on the same scale.
## **Reserves policy and position**
The trustees review the reserves policy annually. As a new charity, that is still in growth mode, our policy is to maintain free reserves sufficient to:
- Cover essential operating costs and committed support for a period of 3–6 months.
- Provide a buffer against income volatility and unexpected calls on funds.
At 31 May 2025, unrestricted general funds were **£47,839** , which represents around one year of recent charitable activity expenditure and a smaller proportion of total annual costs.
The trustees are satisfied that this level of reserves is currently adequate but recognise that it has reduced significantly during the year. It is therefore a priority to:
- Return the charity to at least a break-even position in 2025/26, and
- Rebuild unrestricted reserves over the medium term to a level consistent with the policy.
## **Going concern**
In approving these financial statements, the trustees have considered the charity’s current and forecast financial position, including:
- The level of unrestricted reserves at the balance sheet date.
- The pipeline of confirmed and expected fundraising events and donations.
- The largely variable nature of costs, which can be adjusted if income were to fall.
Having taken these factors into account, the trustees consider that there are no material uncertainties that cast significant doubt on the charity’s ability to continue as a going concern for at least twelve months from the date of approval of these financial statements.
## **Basis of assessment:**
- Cash reserves of £33,673 at year-end, sufficient to meet immediate obligations.
- Active fundraising pipeline including confirmed events and corporate partnerships for 2025/26.
- No borrowings or contingent liabilities.
- Operating cost base (staff, rent, admin) is modest (c. £70k p.a.) and manageable.
- Trustees have line of sight to at least £200k income for 2025/26 based on contracted events and donor commitments.
**Registered in England & Wales | Charity No. 1199115**
**TRUSTEES’ REPORT FY 2024-25 : 6**
**MILITARY VS CANCER**
## **Mitigating actions in place:**
- Monthly cash flow monitoring by trustees.
- Flexible cost base (most costs are variable and linked to events).
- Staff contracts designed to allow scaling if income underperforms.
- Trustee commitment to provide short-term bridging if required (not a formal guarantee, but a practical backstop).
There are no material uncertainties that cast significant doubt on the charity's ability to continue.
## **Principal funding sources**
Our income model is currently **event-dominant** , which brings both opportunities and risks:
## **Opportunities:**
- Events build community, brand awareness, and donor engagement beyond just revenue.
- Military and veteran communities are enthusiastic participants and ambassadors.
- Events generate media coverage and corporate partnership opportunities.
## **Risks:**
- Event income is volatile (weather, economic conditions, competition).
- High gross cost ratios put pressure on net surplus.
- Overreliance on a single income stream limits resilience.
## **2025/26 priorities:**
Diversify income by growing:
- Corporate partnerships and multi-year commitments.
- Trusts & foundations (targeting £30–50k p.a.).
- Regular giving and digital donors (targeting £40k p.a.).
- Legacy marketing (long-term pipeline).
## **Investment policy**
The charity holds no investments other than cash. Given the short-term need for liquidity to fund grants, the trustees do not currently consider it appropriate to invest in longer-term assets.
Cash is held in interest-bearing accounts where possible, balancing return with instant access.
This policy will be reviewed annually as reserves rebuild.
## **TRUSTEE PRIORITIES**
Looking ahead, the trustees’ priorities are to:
- **Review demand for our services** to ensure that what we are currently providing is what our beneficiaries actually need
**Registered in England & Wales | Charity No. 1199115**
**TRUSTEES’ REPORT FY 2024-25 : 7**
**MILITARY VS CANCER**
- **Increase grant-making** to serving personnel, veterans and their families affected by cancer, both in volume and value.
- **Improve fundraising efficiency** , so that a higher proportion of income is available for direct charitable support.
- **Diversify income** beyond events, by strengthening corporate partnerships, developing major donor relationships and applying to trusts and foundations.
- **Consolidate governance and systems** , including impact reporting and financial controls, to support sustainable growth.
The trustees will continue to review the balance between fundraising investment, staffing and direct grants to ensure that the charity delivers maximum impact for beneficiaries while maintaining financial resilience.
## **MEDIUM-TERM PLANS**
## **Strategic priorities for 2025/26 and beyond**
The trustees have approved the following priorities:
## **1. Return to financial surplus**
Target: Break-even or modest surplus (£10–20k) by 31 May 2026.
- Grow income to £320–350k through corporate partnerships, trusts & foundations, and improved event ROI.
- Hold charitable spend at c. £50–60k (grants + casework).
- Contain fundraising costs at <75% of income.
## **2. Increase grant-making capacity**
Target: Deploy £50–60k in direct grants (vs. £27k in 2024/25).
- Proactive outreach to oncology units, unit welfare officers, and partner charities.
- Faster grant decision turnaround (target: 7 days from application to payment).
- Develop case studies and impact measurement to demonstrate ROI to funders.
## **3. Strengthen governance and transparency**
- Develop 3-year strategic plan with clear KPIs.
- Implement quarterly impact reporting to major donors.
- Enhance website with real-time case studies (anonymised, consent-based).
- Pursue quality marks (e.g., Charity Excellence Framework, Fundraising Regulator compliance).
## **4. Build partnerships**
- Formal referral partnerships with NHS oncology units and military welfare teams.
- Corporate partnerships with defence contractors and military-friendly businesses.
**Registered in England & Wales | Charity No. 1199115**
**TRUSTEES’ REPORT FY 2024-25 : 8**
**MILITARY VS CANCER**
- Membership of COBSEO (Confederation of Service Charities) to enhance credibility and collaboration.
## **Long-term vision (3–5 years)**
By 2028, Military vs Cancer aims to be:
- **Deploying £150k+ p.a. in grants** , supporting 50+ families per year.
- **Financially sustainable** with diversified income, modest reserves, and <60p fundraising cost per £1 raised.
- **Nationally recognised** as the go-to charity for Armed Forces cancer support, with strong brand presence and referral pathways across the UK.
- **Evidence-driven** , with robust impact measurement demonstrating outcomes per £1 invested.
We will achieve this by staying true to our military ethos: disciplined execution, relentless focus on mission, and zero tolerance for waste or mediocrity.
## **POST YEAR-END DEVELOPMENTS**
## **Change To Charitable Objects**
After the year end, the trustees reviewed the wording of the charity’s objects in its CIO constitution to ensure that they accurately reflect the way Military vs Cancer now operates and the beneficiaries it serves.
As a result, we have submitted a revised set of objectives to the Charities Commission (March 2026) for approval. These revised objectives:
- Make explicit that our core purpose is **to relieve sickness, hardship and distress among serving members of the UK Armed Forces, veterans and their families who are affected by cancer throughout the British Isles** .
- Clarify that we do this by providing **financial assistance, practical support, information and emotional wellbeing resources** , and by facilitating access to facilities, services, counselling, respite and community programmes.
- Confirm that the trustees may support such other projects or initiatives as they determine from time to time, within the scope of these purposes.
These changes are clarificatory and do not represent a change of direction; they formalise the focus which has already guided our activities in the year under review.
## **Serious Incident**
During the Financial Year covered by this report, the charity received income from sponsorship, events and unrestricted donations.
Following receipt of this income, in early 2026 the trustees became aware of concerns regarding the source of a portion of this income. The trustees have considered this matter and have submitted a Serious Incident Report to the Charity Commission. At the time of approving these accounts, no conclusion has been reached regarding the outcome.
The trustees also identified that certain transactions with suppliers were connected to individuals associated with the charity. The trustees have reviewed these arrangements and are satisfied that the transactions were
**Registered in England & Wales | Charity No. 1199115**
**TRUSTEES’ REPORT FY 2024-25 : 9**
**MILITARY VS CANCER**
undertaken in the course of the charity’s activities. The trustees continue to keep these matters under review. The trustees understand that these concerns may relate to income received over more than one financial period.
The income has been recognised in these accounts in line with the charity’s accounting policies. The trustees will take any further action as appropriate.
## **STATEMENT OF TRUSTEES’ RESPONSIBILITIES**
The charity trustees are responsible for preparing a trustees' annual report and financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the applicable Charities (Accounts and Reports) Regulations, and the provisions of the CIO constitution.
The trustees are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
## **Approval**
This report was approved by the Board of Trustees on **18 March 2026** and signed on its behalf by:
## **C A Nicholson**
Chair of the Board of Trustees
**Registered in England & Wales | Charity No. 1199115**
## **Military v Cancer**
**Charity No. 1199115**
**Trustees' Report and Unaudited Accounts**
**31 May 2025**
**Military v Cancer Contents**
||Pages|
|---|---|
|Trustees' Annual Report|2|
|Independent Examiner's Report|3|
|Statement of Financial Activities|4|
|Balance Sheet|5|
|Statement of Cash flows|14|
|Notes to the Accounts|6 to 13|
|Detailed Statement of Financial Activities|15 to 16|
Page 1
**Military v Cancer Trustees Annual Report**
The trustees present their report with the unaudited financial statements of the charity for the year ended 31 May 2025.
## **REFERENCE AND ADMINISTRATIVE DETAILS**
## **Charity No. 1199115**
## **Trustees**
The following trustees served during the year:
M. Barnes
G. Evans
P. Moody
C.A. Nicholson
## **Accountants**
Accounting for Good CIC 2 Geordie Ridley Place
Upper Precinct Wesley Court Blaydon on Tyne Tyne and Wear NE21 5BT
## **Statement of trustees' responsibilities in relation to the financial statements**
The charity trustees are responsible for preparing a trustees' annual report and financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the applicable Charities (Accounts and Reports) Regulations, and the provisions of the Trust deed. The Trustees are also responsible for safeguarding the assets of the charity and hence taking reasonable steps for the prevention and detection of fraud and other irregularities.
Signed on behalf of the charity's trustees
C.A. Nicholson Trustee 11 March 2026
Page 2
**Military v Cancer Independent Examiners Report**
## **Independent Examiner's Report to the trustees of Military v Cancer**
I report to the trustees on my examination of the financial statements of Military v Cancer for the year ended 31 May 2025.
## **Responsibilities and basis of report**
As the charity's trustees you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011 ('the Act').
I report in respect of my examination of the charity's financial statements carried out under section 145 of the 2011 Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
## **Independent examiner's statement**
As the charity's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination by being a qualified member of FFA FTA.
I have completed my examination. I can confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
- the accounting records were not kept in respect of the charity as required by section 130 of the Act; or
- the financial statements do not accord with those records; or
- the financial statements do not comply with the applicable requirements concerning the form and content of financial statements set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the financial statements give a 'true and fair' view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.
Kay Wightman FFA FTA Accounting for Good CIC 2 Geordie Ridley Place Upper Precinct Wesley Court Blaydon on Tyne Tyne and Wear NE21 5BT 11 March 2026
Page 3
**Military v Cancer Statement of Financial Activities**
## **for the year ended 31 May 2025**
|**Notes**
**Income and endowments**
**from:**
Donations and legacies
3
Charitable activities
4
Other trading activities
5
Other
6
**Total**
**Expenditure on:**
Raising funds
7
Charitable activities
8
Other
10
**Total**
Net gains on investments
**Net (expenditure)/income**
Transfers between funds
**Net (expenditure)/income**
**before other gains/(losses)**
**Other gains and losses**
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**||**Unrestricted**
**funds**|**Restricted**
**funds**|**Total funds**|**Total funds**|
|---|---|---|---|---|---|
|||**2025**|**2025**|**2025**|**2024**|
|||**£**|**£**|**£**|**£**|
|||||||
|||87,193|-|87,193|21,379|
|||-|10,000|10,000|-|
|||178,242|-|178,242|170,948|
|||2,219|-|2,219|3,373|
|||267,654|10,000|277,654|195,700|
|||||||
|||222,050|10,000|232,050|88,544|
|||46,170|-|46,170|79,849|
|||46,529|-|46,529|11,329|
|||314,749|10,000|324,749|179,722|
|||-|-|-|-|
|||(47,095)|-|(47,095)|15,978|
|||-|-|-|-|
|||(47,095)|-|(47,095)|15,978|
|||||||
|||(47,095)|-|(47,095)|15,978|
|||||||
|||94,934|-|94,934|78,956|
|||47,839|-|47,839|94,934|
|||||||
|||||||
|||||||
Page 4
**Military v Cancer Balance Sheet at 31 May 2025**
|**Charity No. 1199115**
**Fixed assets**
Tangible assets
12
**Current assets**
Stocks
13
Debtors
14
Cash at bank and in hand
**Creditors:**Amount falling due within one year
15
**Net current assets**
**Total assets less current liabilities**
**Net assets excluding pension asset or liability**
**Total net assets**
**The funds of the charity**
**Restricted funds**
16
**Unrestricted funds**
16
General funds
**Reserves**
16
**Total funds**|**2025**
**£**
92
92
10,384
5,670
33,673
49,727
(1,980)
47,747
47,839
47,839
47,839
47,839
47,839
47,839|**2024**
**£**
92|
|---|---|---|
|||92
9,570
29,174
56,098|
|||94,842
-|
|||94,842
94,934|
|||94,934|
|||94,934|
|||94,934|
|||94,934|
|||94,934|
Approved by the trustees on 11 March 2026
And signed on their behalf by:
C.A. Nicholson Trustee
11 March 2026
Page 5
**Military v Cancer Notes to the Accounts**
## **for the year ended 31 May 2025**
- 1 **Accounting policies**
## **Basis of preparation**
The financial statements have been prepared in accordance with Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic if Ireland (FRS 102) issued on 16 July 2014 and the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) and the Charities Act 2011.
## **Change in basis of accounting or to previous accounts**
There has been no change to the accounting policies (valuation rules and method of accounting) since last year and no changes have been made to accounts for previous years.
## **Fund accounting**
- Unrestricted funds These are available for use at the discretion of the trustees in furtherance of the general objects of the charity.
- Designated funds These are unrestricted funds earmarked by the trustees for particular purposes. Revaluation funds These are unrestricted funds which include a revaluation reserve representing the restatement of investment assets at their market values.
- Restricted funds These are available for use subject to restrictions imposed by the donor or through terms of an appeal.
## **Income**
- Recognition of Income is included in the Statement of Financial Activities (SoFA) when the charity income becomes entitled to, and virtually certain to receive, the income and the amount of the income can be measured with sufficient reliability.
- Income with related Where income has related expenditure the income and related expenditure is expenditure reported gross in the SoFA.
- Donations and Voluntary income received by way of grants, donations and gifts is included in the legacies the SoFA when receivable and only when the Charity has unconditional entitlement to the income.
- Tax reclaims on Income from tax reclaims is included in the SoFA at the same time as the donations and gifts gift/donation to which it relates. Donated services These are only included in income (with an equivalent amount in expenditure) and facilities where the benefit to the Charity is reasonably quantifiable, measurable and material.
Volunteer help The value of any volunteer help received is not included in the accounts. Investment income This is included in the accounts when receivable. Gains/(losses) on This includes any gain or loss resulting from revaluing investments to market value revaluation of fixed at the end of the year. assets Gains/(losses) on This includes any gain or loss on the sale of investments. investment assets
Page 6
**Military v Cancer Notes to the Accounts**
## **Expenditure**
- Recognition of Expenditure is recognised on an accruals basis. Expenditure includes any VAT which expenditure cannot be fully recovered, and is reported as part of the expenditure to which it relates.
- Expenditure on These comprise the costs associated with attracting voluntary income, fundraising raising funds trading costs and investment management costs. Expenditure on These comprise the costs incurred by the Charity in the delivery of its activities and charitable activities services in the furtherance of its objects, including the making of grants and governance costs.
- Grants payable All grant expenditure is accounted for on an actual paid basis plus an accrual for grants that have been approved by the trustees at the end of the year but not yet paid.
- Governance costs These include those costs associated with meeting the constitutional and statutory requirements of the Charity, including any audit/independent examination fees, costs linked to the strategic management of the Charity, together with a share of other administration costs.
- Other expenditure These are support costs not allocated to a particular activity.
## **Taxation**
The charity is exempt from tax on its charitable activities.
## **Freehold investment property**
Investment properties are measured initially at cost and subsequently at fair value at each balance sheet date and are not depreciated. All gains or losses are taken to the Statement of Financial Activities as they arise.
## **Stocks**
Stock is included at the lower of cost or net realisable value. Donated items of stock are recognised at fair value which is the amount the charity would have been willing to pay for the items on the open market.
## **Trade and other debtors**
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
## **Cash and cash equivalents**
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less and bank overdrafts. In the statement of financial position, bank overdrafts are shown within borrowings or current liabilities. In the Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the company's cash management.
## **Trade and other creditors**
Short term creditors are measured at the transaction price. Other creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.
Page 7
**Military v Cancer Notes to the Accounts**
## **Research and development**
Expenditure on research and development is written off in the year in which it is incurred.
## **Foreign currencies**
Monetary assets and liabilities denominated in currencies other than the functional currency of the charity are translated at the rates of exchange prevailing at the end of the reporting period.
Transactions in currencies other than the functional currency of the charity are recorded at the rate of exchange on the date that the transaction occurred.
All exchange differences are are taken into account in arriving at net income/expenditure.
## **Leased assets**
Where the charity enters into a lease which entails taking substantially all the risks and rewards of ownership of an asset, the lease is treated as a finance lease.
Leases which do not transfer substantially all the risks and rewards of ownership to charity are classified as operating leases.
Assets held under finance leases are initially recognised as assets of the charity at their fair value at the inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding liability to the lessor is included in the balance sheet date as a finance lease obligation. Lease payments are apportioned between finance expenses and reduction of the lease obligation so as to achieve a constant rate of interest on the remaining balance of the liability. Finance expenses are recognised immediately, unless they are directly attributable to qualifying assets, in which case they are capitalised in accordance with the charity's policy on borrowing costs.
Assets held under finance leases are depreciated in the same way as owned assets.
Operating lease payments are recognised as an expense on a straight-line basis over the lease term. In the event that lease incentives are received to enter into operating leases, such incentives are recognised as a liability. The aggregate benefit of incentives is recognised as a reduction of rental expense on a straight-line basis.
## **Pension costs**
The charity operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the charity pays fixed contributions into a separate entity. Once the contributions have been paid the charity has no further payments obligations. The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the charity in independently administered funds.
## **Receipt of donated goods, facilities and services**
All donated goods, facilities and services received are recognised within incoming resources and expenditure at an estimate of the value to the charity.
Page 8
**Military v Cancer Notes to the Accounts**
## 2 **Statement of Financial Activities - prior year**
|**Income and endowments from:**
Donations and legacies
Other trading activities
Other
**Total**
**Expenditure on:**
Raising funds
Charitable activities
Other
**Total**
**Net income**
**Net income before other**
**gains/(losses)**
**Other gains and losses:**
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**
3
**Income from donations and legacies**
Just Giving
Other Donations including
corporate|**Unrestricted**
**£**
24,981
62,212
87,193|**Unrestricted**
**funds**
**2024**
**£**
21,379
107,611
66,710
195,700
88,544
79,849
11,329
179,722
15,978
15,978
15,978
78,956
94,934
**Total**
**2025**
**£**
24,981
62,212
87,193|**Total funds**
**2024**
**£**
21,379
107,611
66,710|
|---|---|---|---|
||||195,700
88,544
79,849
11,329|
||||179,722|
||||15,978|
||||15,978|
||||15,978
78,956|
||||94,934|
||||**Total**
**2024**
**£**
21,379
-|
||||21,379|
|||||
|**Donated goods, facilities and services received**||||
|Donated Prizes||**Total**
**2025**
**£**
11,154
11,154|**Total**
**2024**
**£**
-|
||||-|
Page 9
**Military v Cancer Notes to the Accounts**
## 4 **Income from charitable activities**
|Grants Received
5
**Income from other trading activities**
Events & Crowdfunding
6
**Other income**
Misc Income
7
**Expenditure on raising funds**
_Fundraising trading costs_
Merchandise & Stock
Event Costs
Promotion of Events
Staff Costs
8
**Expenditure on charitable activities**
_Expenditure on charitable_
_activities_
Subcontract Costs
Staff Costs
Grants made
_Governance costs_|**Unrestricted**
**£**
6,570
151,470
33,680
30,330
222,050|**Restricted**
**£**
10,000
10,000
**Unrestricted**
**£**
178,242
178,242
**Unrestricted**
**£**
2,219
2,219|**Total**
**2025**
**£**
10,000
10,000
**Total**
**2025**
**£**
178,242
178,242
**Total**
**2025**
**£**
2,219
2,219|**Total**
**2024**
**£**
-|
|---|---|---|---|---|
|||||-|
|||||**Total**
**2024**
**£**
170,948|
|||||170,948|
|||||**Total**
**2024**
**£**
3,373|
|||||3,373|
||||||
|||**Restricted**
**£**
-
10,000
-
-
10,000
**Unrestricted**
**£**
5,160
13,649
27,361
46,170|**Total**
**2025**
**£**
6,570
161,470
33,680
30,330
232,050
**Total**
**2025**
**£**
5,160
13,649
27,361
46,170|**Total**
**2024**
**£**
6,338
70,259
11,947
-|
|||||88,544|
|||||**Total**
**2024**
**£**
35,625
-
44,224|
|||||79,849|
Page 10
**Military v Cancer Notes to the Accounts**
## 9 **Analysis of grants**
|9|**Analysis of grants**||||
|---|---|---|---|---|
|||**Grants to**|||
||**Activity or programme**|**Individuals**|**Total**|**Total**|
||||**2025**|**2024**|
|||**£**|**£**|**£**|
||Individual Grants|27,361|27,361|44,224|
|||27,361|27,361|44,224|
|||**Grant**|||
|||**funding of**|||
||**Activity or programme**|**activities**|**Total**|**Total**|
||||**2025**|**2024**|
|||**£**|**£**|**£**|
||Individual Grants|27,361|27,361|44,224|
|||27,361|27,361|44,224|
|10|**Other expenditure**||||
|||**Unrestricted**|**Total**|**Total**|
||||**2025**|**2024**|
|||**£**|**£**|**£**|
||Employee costs|16,682|16,682|81|
||Motor and travel costs|6,927|6,927|1,720|
||Premises costs|11,258|11,258|1,849|
||General administrative costs|6,194|6,194|5,997|
||Legal and professional costs|5,468|5,468|1,682|
|||46,529|46,529|11,329|
|11|**Staff costs**||||
|||**2025**||**2024**|
||Salaries and wages|14,808||-|
||Social security costs|1,520||-|
||Pension costs|1,288||-|
|||17,616||-|
||No employee received emoluments in excess of £60,000.||||
||The average monthly number of full time equivalent employees during the year was as follows:||||
|||**2025**||**2024**|
|||**Number**||**Number**|
||Management|2||-|
|||2||-|
Page 11
**Military v Cancer Notes to the Accounts**
## 12 **Tangible fixed assets**
|**Cost or revaluation**
At 1 June 2024
At 31 May 2025
**Net book values**
At 31 May 2025
At 31 May 2024
13 **Stocks**
Finished goods
**Carrying value analysed by activities**
Events & Crowdfunding
14 **Debtors**
Trade debtors
Other debtors
Prepayments and accrued income
15 **Creditors:**
amounts falling due within one year
Accruals|**2025**
**£**
10,384
10,384
**2025**
**£**
10,384
10,384
**2025**
**£**
2,238
2,535
897
5,670
**2025**
**£**|**£**
92
92
92
92|**£**
92|
|---|---|---|---|
||||92|
||||92|
||||92|
||||**2024**
**£**
9,570|
||||9,570|
||||**2024**
**£**
9,570|
||||9,570|
||||**2024**
**£**
10,918
-
18,256|
||||29,174|
||||**2024**
**£**|
||1,980||-|
||1,980||-|
Page 12
**Military v Cancer Notes to the Accounts**
## 16 **Movement in funds**
|16 **Movement in funds**||||
|---|---|---|---|
|**At 1 June**
**2024**
**Incoming**
**resources**
**(including**
**other**
**gains/losses**
**)**
**£**
**Restricted funds:**
**Restricted income funds:**
Event Costs
-
10,000
_Total_
-
10,000
**Unrestricted funds:**
**General funds**
94,934
267,654
**Total funds**
94,934
277,654
Purposes and restrictions in relation to the funds:
Restricted funds:
Event Costs
Grant toward cost of Armed Forces Day
17 **Analysis of net assets between funds**
Fixed assets
Net current assets
18 **Reconciliation of net debt**
**At 1 June**
**2024**
**£**
Cash and cash equivalents
56,098
56,098
Net debt
56,098|**Incoming**
**resources**
**(including**
**other**
**gains/losses**
**)**
**£**
10,000
10,000
267,654
277,654|**Resources**
**expended**
**£**
(10,000)
(10,000)
(314,749)
(324,749)|**At 31 May**
**2025**
**£**
-|
||||-|
||||47,839|
||||47,839|
|||||
|||||
|||||
||**At 1 June**
**2024**
**£**|**Unrestricted**
**funds**
**£**
92
47,747
47,839
**Cash flows**
**£**|**Total**
**£**
92
47,747|
||||47,839|
||||**At 31 May**
**2025**
**£**|
||56,098|(22,425)|33,673|
||56,098
56,098|(22,425)
(22,425)|33,673|
||||33,673|
|||||
Page 13
**Military v Cancer Notes to the Accounts**
## 19 **Commitments**
## _**Operating lease commitments**_
Annual commitments under non-cancellable operating leases are as follows:
||**2025**|**2025**|**2024**|**2024**|
|---|---|---|---|---|
||**Land and**
**buildings**|**Other**|**Land and**
**buildings**|**Other**|
||**£**|**£**|**£**|**£**|
|Operating leases with expiry date:|||||
|**_Pension commitments_**|||||
|||**2025**||**2024**|
|||**£**||**£**|
|The pension cost charge to the charity|||||
|amounted to:||354||-|
Page 14
**Military v Cancer Statement of Cash flows for the year ended 31 May 2025**
|**Cash flows from operating activities**
**Net (expenditure)/income per Statement of Financial Activities**
**Adjustments for:**
Dividends, interest and rents from investments
Increase in stocks
Decrease/(Increase) in trade and other receivables
Increase in trade and other payables
**Net cash used in operating activities**
**Cash flows from investing activities**
Dividends, interest and rents from investments
**Net cash from investing activities**
**Net cash from financing activities**
**Net decrease in cash and cash equivalents**
**Cash and cash equivalents at the beginning of the year**
**Cash and cash equivalents at the end of the year**|**2025**
**£**
(47,095)
(2,219)
(814)
23,504
1,980
(24,644)
2,219
2,219
-
(22,425)
56,098
33,673|**2024**
**£**
15,978
(66,710)
(9,570)
(29,174)
-|
|---|---|---|
|||(89,476)
66,710|
|||66,618|
||||
|||-|
||||
|||(22,858)|
|||-|
|||(22,858)|
||||
|**Components of cash and cash equivalents**|||
|Cash and bank balances|33,673|56,098|
||||
||33,673|56,098|
Page 15
**Military v Cancer Detailed Statement of Financial Activities**
## **for the year ended 31 May 2025**
|**Income and endowments from:**
Donations and legacies
Just Giving
Other Donations including
corporate
Charitable activities
Grants Received
Other trading activities
Events & Crowdfunding
Other
Misc Income
**Total income and endowments**
**Expenditure on:**
Costs of other trading activities
Merchandise & Stock
Event Costs
Promotion of Events
Staff Costs
**Total of expenditure on raising**
**funds**
Charitable activities
Subcontract Costs
Staff Costs
Grants made
**Total of expenditure on charitable**
**activities**
Employee costs
Salaries/wages
Employer's NIC
Pension costs
Staff training
Motor and travel costs|**Unrestricte**
**d funds**
**2025**
**£**
24,981
62,212
87,193
-
-
178,242
178,242
2,219
2,219
267,654
6,570
151,470
33,680
30,330
222,050
222,050
5,160
13,649
27,361
46,170
46,170
14,808
1,520
354
-
16,682|**Restricted**
**funds**
**2025**
**£**
-
-
-
10,000
10,000
-
-
-
-
10,000
-
10,000
-
-
10,000
10,000
-
-
-
-
-
-
-
-
-
-|**Total funds**
**2025**
**£**
24,981
62,212
87,193
10,000
10,000
178,242
178,242
2,219
2,219
277,654
6,570
161,470
33,680
30,330
232,050
232,050
5,160
13,649
27,361
46,170
46,170
14,808
1,520
354
-
16,682|**Total funds**
**2024**
**£**
21,379
-|
|---|---|---|---|---|
|||||21,379|
|||||-|
|||||-|
|||||170,948|
|||||170,948|
|||||3,373|
|||||3,373|
|||||195,700
6,338
70,259
11,947
-|
|||||88,544|
|||||88,544
35,625
-
44,224|
|||||79,849|
|||||79,849
-
-
-
81|
|||||81|
||||||
Page 16
## **Military v Cancer**
## **Detailed Statement of Financial Activities**
|Travel and subsistence
Premises costs
Rent
Rates
Other premises costs
General administrative costs,
including depreciation and
amortisation
Bank charges
General insurances
Information and publications
Postage and couriers
Software, IT support and related
costs
Stationery and printing
Subscriptions
Sundry expenses
Telephone, fax and broadband
Legal and professional costs
Audit/Independent examination
fees
Accountancy and bookkeeping
Consultancy fees
Solicitor's fees
**Total of expenditure of other costs**
**Total expenditure**
Net gains on investments
**Net (expenditure)/income**
**Net (expenditure)/income before**
**other gains/(losses)**
Other Gains
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**|6,927
6,927
4,345
64
6,849
11,258
105
698
1,185
207
33
657
1,175
1,890
244
6,194
1,980
83
3,405
-
5,468
46,529
314,749
-
(47,095)
(47,095)
-
(47,095)
94,934
47,839|-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
10,000
-
-
-
-
-
-
-|6,927
6,927
4,345
64
6,849
11,258
105
698
1,185
207
33
657
1,175
1,890
244
6,194
1,980
83
3,405
-
5,468
46,529
324,749
-
(47,095)
(47,095)
-
(47,095)
94,934
47,839|1,720|
|---|---|---|---|---|
|||||1,720|
|||||-
-
1,849|
|||||1,849|
|||||-
1,617
1,709
913
80
522
892
25
239|
|||||5,997|
|||||-
-
1,662
20|
|||||1,682|
||||||
|||||11,329|
|||||179,722
-|
|||||15,978|
|||||15,978
-|
|||||15,978|
|||||78,956|
|||||94,934|
Page 17
## **Military v Cancer**
**Charity No. 1199115**
**Trustees' Report and Unaudited Accounts**
**31 May 2025**
**Military v Cancer Contents**
||Pages|
|---|---|
|Trustees' Annual Report|2|
|Independent Examiner's Report|3|
|Statement of Financial Activities|4|
|Balance Sheet|5|
|Statement of Cash flows|14|
|Notes to the Accounts|6 to 13|
|Detailed Statement of Financial Activities|15 to 16|
Page 1
**Military v Cancer Trustees Annual Report**
The trustees present their report with the unaudited financial statements of the charity for the year ended 31 May 2025.
## **REFERENCE AND ADMINISTRATIVE DETAILS**
## **Charity No. 1199115**
## **Trustees**
The following trustees served during the year:
M. Barnes
G. Evans
P. Moody
C.A. Nicholson
## **Accountants**
Accounting for Good CIC 2 Geordie Ridley Place
Upper Precinct Wesley Court Blaydon on Tyne Tyne and Wear NE21 5BT
## **Statement of trustees' responsibilities in relation to the financial statements**
The charity trustees are responsible for preparing a trustees' annual report and financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the applicable Charities (Accounts and Reports) Regulations, and the provisions of the Trust deed. The Trustees are also responsible for safeguarding the assets of the charity and hence taking reasonable steps for the prevention and detection of fraud and other irregularities.
Signed on behalf of the charity's trustees
C.A. Nicholson Trustee 11 March 2026
Page 2
**Military v Cancer Independent Examiners Report**
## **Independent Examiner's Report to the trustees of Military v Cancer**
I report to the trustees on my examination of the financial statements of Military v Cancer for the year ended 31 May 2025.
## **Responsibilities and basis of report**
As the charity's trustees you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011 ('the Act').
I report in respect of my examination of the charity's financial statements carried out under section 145 of the 2011 Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
## **Independent examiner's statement**
As the charity's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination by being a qualified member of FFA FTA.
I have completed my examination. I can confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
- the accounting records were not kept in respect of the charity as required by section 130 of the Act; or
- the financial statements do not accord with those records; or
- the financial statements do not comply with the applicable requirements concerning the form and content of financial statements set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the financial statements give a 'true and fair' view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.
Kay Wightman FFA FTA Accounting for Good CIC 2 Geordie Ridley Place Upper Precinct Wesley Court Blaydon on Tyne Tyne and Wear NE21 5BT 11 March 2026
Page 3
**Military v Cancer Statement of Financial Activities**
## **for the year ended 31 May 2025**
|**Notes**
**Income and endowments**
**from:**
Donations and legacies
3
Charitable activities
4
Other trading activities
5
Other
6
**Total**
**Expenditure on:**
Raising funds
7
Charitable activities
8
Other
10
**Total**
Net gains on investments
**Net (expenditure)/income**
Transfers between funds
**Net (expenditure)/income**
**before other gains/(losses)**
**Other gains and losses**
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**||**Unrestricted**
**funds**|**Restricted**
**funds**|**Total funds**|**Total funds**|
|---|---|---|---|---|---|
|||**2025**|**2025**|**2025**|**2024**|
|||**£**|**£**|**£**|**£**|
|||||||
|||87,193|-|87,193|21,379|
|||-|10,000|10,000|-|
|||178,242|-|178,242|170,948|
|||2,219|-|2,219|3,373|
|||267,654|10,000|277,654|195,700|
|||||||
|||222,050|10,000|232,050|88,544|
|||46,170|-|46,170|79,849|
|||46,529|-|46,529|11,329|
|||314,749|10,000|324,749|179,722|
|||-|-|-|-|
|||(47,095)|-|(47,095)|15,978|
|||-|-|-|-|
|||(47,095)|-|(47,095)|15,978|
|||||||
|||(47,095)|-|(47,095)|15,978|
|||||||
|||94,934|-|94,934|78,956|
|||47,839|-|47,839|94,934|
|||||||
|||||||
|||||||
Page 4
**Military v Cancer Balance Sheet at 31 May 2025**
|**Charity No. 1199115**
**Fixed assets**
Tangible assets
12
**Current assets**
Stocks
13
Debtors
14
Cash at bank and in hand
**Creditors:**Amount falling due within one year
15
**Net current assets**
**Total assets less current liabilities**
**Net assets excluding pension asset or liability**
**Total net assets**
**The funds of the charity**
**Restricted funds**
16
**Unrestricted funds**
16
General funds
**Reserves**
16
**Total funds**|**2025**
**£**
92
92
10,384
5,670
33,673
49,727
(1,980)
47,747
47,839
47,839
47,839
47,839
47,839
47,839|**2024**
**£**
92|
|---|---|---|
|||92
9,570
29,174
56,098|
|||94,842
-|
|||94,842
94,934|
|||94,934|
|||94,934|
|||94,934|
|||94,934|
|||94,934|
Approved by the trustees on 11 March 2026
And signed on their behalf by:
C.A. Nicholson Trustee
11 March 2026
Page 5
**Military v Cancer Notes to the Accounts**
## **for the year ended 31 May 2025**
- 1 **Accounting policies**
## **Basis of preparation**
The financial statements have been prepared in accordance with Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic if Ireland (FRS 102) issued on 16 July 2014 and the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) and the Charities Act 2011.
## **Change in basis of accounting or to previous accounts**
There has been no change to the accounting policies (valuation rules and method of accounting) since last year and no changes have been made to accounts for previous years.
## **Fund accounting**
- Unrestricted funds These are available for use at the discretion of the trustees in furtherance of the general objects of the charity.
- Designated funds These are unrestricted funds earmarked by the trustees for particular purposes. Revaluation funds These are unrestricted funds which include a revaluation reserve representing the restatement of investment assets at their market values.
- Restricted funds These are available for use subject to restrictions imposed by the donor or through terms of an appeal.
## **Income**
- Recognition of Income is included in the Statement of Financial Activities (SoFA) when the charity income becomes entitled to, and virtually certain to receive, the income and the amount of the income can be measured with sufficient reliability.
- Income with related Where income has related expenditure the income and related expenditure is expenditure reported gross in the SoFA.
- Donations and Voluntary income received by way of grants, donations and gifts is included in the legacies the SoFA when receivable and only when the Charity has unconditional entitlement to the income.
- Tax reclaims on Income from tax reclaims is included in the SoFA at the same time as the donations and gifts gift/donation to which it relates. Donated services These are only included in income (with an equivalent amount in expenditure) and facilities where the benefit to the Charity is reasonably quantifiable, measurable and material.
Volunteer help The value of any volunteer help received is not included in the accounts. Investment income This is included in the accounts when receivable. Gains/(losses) on This includes any gain or loss resulting from revaluing investments to market value revaluation of fixed at the end of the year. assets Gains/(losses) on This includes any gain or loss on the sale of investments. investment assets
Page 6
**Military v Cancer Notes to the Accounts**
## **Expenditure**
- Recognition of Expenditure is recognised on an accruals basis. Expenditure includes any VAT which expenditure cannot be fully recovered, and is reported as part of the expenditure to which it relates.
- Expenditure on These comprise the costs associated with attracting voluntary income, fundraising raising funds trading costs and investment management costs. Expenditure on These comprise the costs incurred by the Charity in the delivery of its activities and charitable activities services in the furtherance of its objects, including the making of grants and governance costs.
- Grants payable All grant expenditure is accounted for on an actual paid basis plus an accrual for grants that have been approved by the trustees at the end of the year but not yet paid.
- Governance costs These include those costs associated with meeting the constitutional and statutory requirements of the Charity, including any audit/independent examination fees, costs linked to the strategic management of the Charity, together with a share of other administration costs.
- Other expenditure These are support costs not allocated to a particular activity.
## **Taxation**
The charity is exempt from tax on its charitable activities.
## **Freehold investment property**
Investment properties are measured initially at cost and subsequently at fair value at each balance sheet date and are not depreciated. All gains or losses are taken to the Statement of Financial Activities as they arise.
## **Stocks**
Stock is included at the lower of cost or net realisable value. Donated items of stock are recognised at fair value which is the amount the charity would have been willing to pay for the items on the open market.
## **Trade and other debtors**
Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
## **Cash and cash equivalents**
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less and bank overdrafts. In the statement of financial position, bank overdrafts are shown within borrowings or current liabilities. In the Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the company's cash management.
## **Trade and other creditors**
Short term creditors are measured at the transaction price. Other creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.
Page 7
**Military v Cancer Notes to the Accounts**
## **Research and development**
Expenditure on research and development is written off in the year in which it is incurred.
## **Foreign currencies**
Monetary assets and liabilities denominated in currencies other than the functional currency of the charity are translated at the rates of exchange prevailing at the end of the reporting period.
Transactions in currencies other than the functional currency of the charity are recorded at the rate of exchange on the date that the transaction occurred.
All exchange differences are are taken into account in arriving at net income/expenditure.
## **Leased assets**
Where the charity enters into a lease which entails taking substantially all the risks and rewards of ownership of an asset, the lease is treated as a finance lease.
Leases which do not transfer substantially all the risks and rewards of ownership to charity are classified as operating leases.
Assets held under finance leases are initially recognised as assets of the charity at their fair value at the inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding liability to the lessor is included in the balance sheet date as a finance lease obligation. Lease payments are apportioned between finance expenses and reduction of the lease obligation so as to achieve a constant rate of interest on the remaining balance of the liability. Finance expenses are recognised immediately, unless they are directly attributable to qualifying assets, in which case they are capitalised in accordance with the charity's policy on borrowing costs.
Assets held under finance leases are depreciated in the same way as owned assets.
Operating lease payments are recognised as an expense on a straight-line basis over the lease term. In the event that lease incentives are received to enter into operating leases, such incentives are recognised as a liability. The aggregate benefit of incentives is recognised as a reduction of rental expense on a straight-line basis.
## **Pension costs**
The charity operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the charity pays fixed contributions into a separate entity. Once the contributions have been paid the charity has no further payments obligations. The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the charity in independently administered funds.
## **Receipt of donated goods, facilities and services**
All donated goods, facilities and services received are recognised within incoming resources and expenditure at an estimate of the value to the charity.
Page 8
**Military v Cancer Notes to the Accounts**
## 2 **Statement of Financial Activities - prior year**
|**Income and endowments from:**
Donations and legacies
Other trading activities
Other
**Total**
**Expenditure on:**
Raising funds
Charitable activities
Other
**Total**
**Net income**
**Net income before other**
**gains/(losses)**
**Other gains and losses:**
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**
3
**Income from donations and legacies**
Just Giving
Other Donations including
corporate|**Unrestricted**
**£**
24,981
62,212
87,193|**Unrestricted**
**funds**
**2024**
**£**
21,379
107,611
66,710
195,700
88,544
79,849
11,329
179,722
15,978
15,978
15,978
78,956
94,934
**Total**
**2025**
**£**
24,981
62,212
87,193|**Total funds**
**2024**
**£**
21,379
107,611
66,710|
|---|---|---|---|
||||195,700
88,544
79,849
11,329|
||||179,722|
||||15,978|
||||15,978|
||||15,978
78,956|
||||94,934|
||||**Total**
**2024**
**£**
21,379
-|
||||21,379|
|||||
|**Donated goods, facilities and services received**||||
|Donated Prizes||**Total**
**2025**
**£**
11,154
11,154|**Total**
**2024**
**£**
-|
||||-|
Page 9
**Military v Cancer Notes to the Accounts**
## 4 **Income from charitable activities**
|Grants Received
5
**Income from other trading activities**
Events & Crowdfunding
6
**Other income**
Misc Income
7
**Expenditure on raising funds**
_Fundraising trading costs_
Merchandise & Stock
Event Costs
Promotion of Events
Staff Costs
8
**Expenditure on charitable activities**
_Expenditure on charitable_
_activities_
Subcontract Costs
Staff Costs
Grants made
_Governance costs_|**Unrestricted**
**£**
6,570
151,470
33,680
30,330
222,050|**Restricted**
**£**
10,000
10,000
**Unrestricted**
**£**
178,242
178,242
**Unrestricted**
**£**
2,219
2,219|**Total**
**2025**
**£**
10,000
10,000
**Total**
**2025**
**£**
178,242
178,242
**Total**
**2025**
**£**
2,219
2,219|**Total**
**2024**
**£**
-|
|---|---|---|---|---|
|||||-|
|||||**Total**
**2024**
**£**
170,948|
|||||170,948|
|||||**Total**
**2024**
**£**
3,373|
|||||3,373|
||||||
|||**Restricted**
**£**
-
10,000
-
-
10,000
**Unrestricted**
**£**
5,160
13,649
27,361
46,170|**Total**
**2025**
**£**
6,570
161,470
33,680
30,330
232,050
**Total**
**2025**
**£**
5,160
13,649
27,361
46,170|**Total**
**2024**
**£**
6,338
70,259
11,947
-|
|||||88,544|
|||||**Total**
**2024**
**£**
35,625
-
44,224|
|||||79,849|
Page 10
**Military v Cancer Notes to the Accounts**
## 9 **Analysis of grants**
|9|**Analysis of grants**||||
|---|---|---|---|---|
|||**Grants to**|||
||**Activity or programme**|**Individuals**|**Total**|**Total**|
||||**2025**|**2024**|
|||**£**|**£**|**£**|
||Individual Grants|27,361|27,361|44,224|
|||27,361|27,361|44,224|
|||**Grant**|||
|||**funding of**|||
||**Activity or programme**|**activities**|**Total**|**Total**|
||||**2025**|**2024**|
|||**£**|**£**|**£**|
||Individual Grants|27,361|27,361|44,224|
|||27,361|27,361|44,224|
|10|**Other expenditure**||||
|||**Unrestricted**|**Total**|**Total**|
||||**2025**|**2024**|
|||**£**|**£**|**£**|
||Employee costs|16,682|16,682|81|
||Motor and travel costs|6,927|6,927|1,720|
||Premises costs|11,258|11,258|1,849|
||General administrative costs|6,194|6,194|5,997|
||Legal and professional costs|5,468|5,468|1,682|
|||46,529|46,529|11,329|
|11|**Staff costs**||||
|||**2025**||**2024**|
||Salaries and wages|14,808||-|
||Social security costs|1,520||-|
||Pension costs|1,288||-|
|||17,616||-|
||No employee received emoluments in excess of £60,000.||||
||The average monthly number of full time equivalent employees during the year was as follows:||||
|||**2025**||**2024**|
|||**Number**||**Number**|
||Management|2||-|
|||2||-|
Page 11
**Military v Cancer Notes to the Accounts**
## 12 **Tangible fixed assets**
|**Cost or revaluation**
At 1 June 2024
At 31 May 2025
**Net book values**
At 31 May 2025
At 31 May 2024
13 **Stocks**
Finished goods
**Carrying value analysed by activities**
Events & Crowdfunding
14 **Debtors**
Trade debtors
Other debtors
Prepayments and accrued income
15 **Creditors:**
amounts falling due within one year
Accruals|**2025**
**£**
10,384
10,384
**2025**
**£**
10,384
10,384
**2025**
**£**
2,238
2,535
897
5,670
**2025**
**£**|**£**
92
92
92
92|**£**
92|
|---|---|---|---|
||||92|
||||92|
||||92|
||||**2024**
**£**
9,570|
||||9,570|
||||**2024**
**£**
9,570|
||||9,570|
||||**2024**
**£**
10,918
-
18,256|
||||29,174|
||||**2024**
**£**|
||1,980||-|
||1,980||-|
Page 12
**Military v Cancer Notes to the Accounts**
## 16 **Movement in funds**
|16 **Movement in funds**||||
|---|---|---|---|
|**At 1 June**
**2024**
**Incoming**
**resources**
**(including**
**other**
**gains/losses**
**)**
**£**
**Restricted funds:**
**Restricted income funds:**
Event Costs
-
10,000
_Total_
-
10,000
**Unrestricted funds:**
**General funds**
94,934
267,654
**Total funds**
94,934
277,654
Purposes and restrictions in relation to the funds:
Restricted funds:
Event Costs
Grant toward cost of Armed Forces Day
17 **Analysis of net assets between funds**
Fixed assets
Net current assets
18 **Reconciliation of net debt**
**At 1 June**
**2024**
**£**
Cash and cash equivalents
56,098
56,098
Net debt
56,098|**Incoming**
**resources**
**(including**
**other**
**gains/losses**
**)**
**£**
10,000
10,000
267,654
277,654|**Resources**
**expended**
**£**
(10,000)
(10,000)
(314,749)
(324,749)|**At 31 May**
**2025**
**£**
-|
||||-|
||||47,839|
||||47,839|
|||||
|||||
|||||
||**At 1 June**
**2024**
**£**|**Unrestricted**
**funds**
**£**
92
47,747
47,839
**Cash flows**
**£**|**Total**
**£**
92
47,747|
||||47,839|
||||**At 31 May**
**2025**
**£**|
||56,098|(22,425)|33,673|
||56,098
56,098|(22,425)
(22,425)|33,673|
||||33,673|
|||||
Page 13
**Military v Cancer Notes to the Accounts**
## 19 **Commitments**
## _**Operating lease commitments**_
Annual commitments under non-cancellable operating leases are as follows:
||**2025**|**2025**|**2024**|**2024**|
|---|---|---|---|---|
||**Land and**
**buildings**|**Other**|**Land and**
**buildings**|**Other**|
||**£**|**£**|**£**|**£**|
|Operating leases with expiry date:|||||
|**_Pension commitments_**|||||
|||**2025**||**2024**|
|||**£**||**£**|
|The pension cost charge to the charity|||||
|amounted to:||354||-|
Page 14
**Military v Cancer Statement of Cash flows for the year ended 31 May 2025**
|**Cash flows from operating activities**
**Net (expenditure)/income per Statement of Financial Activities**
**Adjustments for:**
Dividends, interest and rents from investments
Increase in stocks
Decrease/(Increase) in trade and other receivables
Increase in trade and other payables
**Net cash used in operating activities**
**Cash flows from investing activities**
Dividends, interest and rents from investments
**Net cash from investing activities**
**Net cash from financing activities**
**Net decrease in cash and cash equivalents**
**Cash and cash equivalents at the beginning of the year**
**Cash and cash equivalents at the end of the year**|**2025**
**£**
(47,095)
(2,219)
(814)
23,504
1,980
(24,644)
2,219
2,219
-
(22,425)
56,098
33,673|**2024**
**£**
15,978
(66,710)
(9,570)
(29,174)
-|
|---|---|---|
|||(89,476)
66,710|
|||66,618|
||||
|||-|
||||
|||(22,858)|
|||-|
|||(22,858)|
||||
|**Components of cash and cash equivalents**|||
|Cash and bank balances|33,673|56,098|
||||
||33,673|56,098|
Page 15
**Military v Cancer Detailed Statement of Financial Activities**
## **for the year ended 31 May 2025**
|**Income and endowments from:**
Donations and legacies
Just Giving
Other Donations including
corporate
Charitable activities
Grants Received
Other trading activities
Events & Crowdfunding
Other
Misc Income
**Total income and endowments**
**Expenditure on:**
Costs of other trading activities
Merchandise & Stock
Event Costs
Promotion of Events
Staff Costs
**Total of expenditure on raising**
**funds**
Charitable activities
Subcontract Costs
Staff Costs
Grants made
**Total of expenditure on charitable**
**activities**
Employee costs
Salaries/wages
Employer's NIC
Pension costs
Staff training
Motor and travel costs|**Unrestricte**
**d funds**
**2025**
**£**
24,981
62,212
87,193
-
-
178,242
178,242
2,219
2,219
267,654
6,570
151,470
33,680
30,330
222,050
222,050
5,160
13,649
27,361
46,170
46,170
14,808
1,520
354
-
16,682|**Restricted**
**funds**
**2025**
**£**
-
-
-
10,000
10,000
-
-
-
-
10,000
-
10,000
-
-
10,000
10,000
-
-
-
-
-
-
-
-
-
-|**Total funds**
**2025**
**£**
24,981
62,212
87,193
10,000
10,000
178,242
178,242
2,219
2,219
277,654
6,570
161,470
33,680
30,330
232,050
232,050
5,160
13,649
27,361
46,170
46,170
14,808
1,520
354
-
16,682|**Total funds**
**2024**
**£**
21,379
-|
|---|---|---|---|---|
|||||21,379|
|||||-|
|||||-|
|||||170,948|
|||||170,948|
|||||3,373|
|||||3,373|
|||||195,700
6,338
70,259
11,947
-|
|||||88,544|
|||||88,544
35,625
-
44,224|
|||||79,849|
|||||79,849
-
-
-
81|
|||||81|
||||||
Page 16
## **Military v Cancer**
## **Detailed Statement of Financial Activities**
|Travel and subsistence
Premises costs
Rent
Rates
Other premises costs
General administrative costs,
including depreciation and
amortisation
Bank charges
General insurances
Information and publications
Postage and couriers
Software, IT support and related
costs
Stationery and printing
Subscriptions
Sundry expenses
Telephone, fax and broadband
Legal and professional costs
Audit/Independent examination
fees
Accountancy and bookkeeping
Consultancy fees
Solicitor's fees
**Total of expenditure of other costs**
**Total expenditure**
Net gains on investments
**Net (expenditure)/income**
**Net (expenditure)/income before**
**other gains/(losses)**
Other Gains
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
**Total funds carried forward**|6,927
6,927
4,345
64
6,849
11,258
105
698
1,185
207
33
657
1,175
1,890
244
6,194
1,980
83
3,405
-
5,468
46,529
314,749
-
(47,095)
(47,095)
-
(47,095)
94,934
47,839|-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
10,000
-
-
-
-
-
-
-|6,927
6,927
4,345
64
6,849
11,258
105
698
1,185
207
33
657
1,175
1,890
244
6,194
1,980
83
3,405
-
5,468
46,529
324,749
-
(47,095)
(47,095)
-
(47,095)
94,934
47,839|1,720|
|---|---|---|---|---|
|||||1,720|
|||||-
-
1,849|
|||||1,849|
|||||-
1,617
1,709
913
80
522
892
25
239|
|||||5,997|
|||||-
-
1,662
20|
|||||1,682|
||||||
|||||11,329|
|||||179,722
-|
|||||15,978|
|||||15,978
-|
|||||15,978|
|||||78,956|
|||||94,934|
Page 17